+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Severe Acute Respiratory Syndrome"

From
Global Diagnostics Labs Market Outlook, 2029 - Product Thumbnail Image

Global Diagnostics Labs Market Outlook, 2029

  • Report
  • January 2024
  • 163 Pages
  • Global
From
From
Coronavirus Test Kits Market in APAC 2023-2027 - Product Thumbnail Image

Coronavirus Test Kits Market in APAC 2023-2027

  • Report
  • October 2023
  • 149 Pages
  • Asia Pacific
From
Coronavirus Test Kits Market in Europe 2023-2027 - Product Thumbnail Image

Coronavirus Test Kits Market in Europe 2023-2027

  • Report
  • October 2023
  • 147 Pages
  • Europe
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses. Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution. Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more